232 related articles for article (PubMed ID: 19617566)
1. Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers.
Guda K; Moinova H; He J; Jamison O; Ravi L; Natale L; Lutterbaugh J; Lawrence E; Lewis S; Willson JK; Lowe JB; Wiesner GL; Parmigiani G; Barnholtz-Sloan J; Dawson DW; Velculescu VE; Kinzler KW; Papadopoulos N; Vogelstein B; Willis J; Gerken TA; Markowitz SD
Proc Natl Acad Sci U S A; 2009 Aug; 106(31):12921-5. PubMed ID: 19617566
[TBL] [Abstract][Full Text] [Related]
2. GALNT12 suppresses the bone-specific prostate cancer metastasis by activating BMP pathway via the O-glycosylation of BMPR1A.
Yang Y; Ding M; Yin H; Chen W; Shen H; Diao W; Yang L; Qin H; Gan W; Qiu X; Guo H
Int J Biol Sci; 2024; 20(4):1297-1313. PubMed ID: 38385080
[TBL] [Abstract][Full Text] [Related]
3. Evidence for GALNT12 as a moderate penetrance gene for colorectal cancer.
Evans DR; Venkitachalam S; Revoredo L; Dohey AT; Clarke E; Pennell JJ; Powell AE; Quinn E; Ravi L; Gerken TA; Green JS; Woods MO; Guda K
Hum Mutat; 2018 Aug; 39(8):1092-1101. PubMed ID: 29749045
[TBL] [Abstract][Full Text] [Related]
4.
Lavrsen K; Dabelsteen S; Vakhrushev SY; Levann AMR; Haue AD; Dylander A; Mandel U; Hansen L; Frödin M; Bennett EP; Wandall HH
J Biol Chem; 2018 Jan; 293(4):1298-1314. PubMed ID: 29187600
[TBL] [Abstract][Full Text] [Related]
5. GALNT12 is associated with the malignancy of glioma and promotes glioblastoma multiforme in vitro by activating Akt signaling.
Zheng Y; Liang M; Wang B; Kang L; Yuan Y; Mao Y; Wang S
Biochem Biophys Res Commun; 2022 Jun; 610():99-106. PubMed ID: 35461073
[TBL] [Abstract][Full Text] [Related]
6. Clinically significant missense variants in human GALNT3, GALNT8, GALNT12, and GALNT13 genes: intriguing in silico findings.
Hussain MRM; Nasir J; Al-Aama JY
J Cell Biochem; 2014 Feb; 115(2):313-27. PubMed ID: 24038392
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and functional characterization of glycosylation-associated mutational landscapes in colon cancer.
Venkitachalam S; Revoredo L; Varadan V; Fecteau RE; Ravi L; Lutterbaugh J; Markowitz SD; Willis JE; Gerken TA; Guda K
Sci Rep; 2016 Mar; 6():23642. PubMed ID: 27004849
[TBL] [Abstract][Full Text] [Related]
8. Loss of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 3 and reduced O-glycosylation in colon carcinoma cells selected for hepatic metastasis.
Kato K; Takeuchi H; Kanoh A; Miyahara N; Nemoto-Sasaki Y; Morimoto-Tomita M; Matsubara A; Ohashi Y; Waki M; Usami K; Mandel U; Clausen H; Higashi N; Irimura T
Glycoconj J; 2010 Feb; 27(2):267-76. PubMed ID: 20077002
[TBL] [Abstract][Full Text] [Related]
9. Critical roles of mucin 1 glycosylation by transactivated polypeptide N-acetylgalactosaminyltransferase 6 in mammary carcinogenesis.
Park JH; Nishidate T; Kijima K; Ohashi T; Takegawa K; Fujikane T; Hirata K; Nakamura Y; Katagiri T
Cancer Res; 2010 Apr; 70(7):2759-69. PubMed ID: 20215525
[TBL] [Abstract][Full Text] [Related]
10. GALNT12 is not a major contributor of familial colorectal cancer type X.
Seguí N; Pineda M; Navarro M; Lázaro C; Brunet J; Infante M; Durán M; Soto JL; Blanco I; Capellá G; Valle L
Hum Mutat; 2014 Jan; 35(1):50-2. PubMed ID: 24115450
[TBL] [Abstract][Full Text] [Related]
11. Inherited deleterious variants in GALNT12 are associated with CRC susceptibility.
Clarke E; Green RC; Green JS; Mahoney K; Parfrey PS; Younghusband HB; Woods MO
Hum Mutat; 2012 Jul; 33(7):1056-8. PubMed ID: 22461326
[TBL] [Abstract][Full Text] [Related]
12. Primary Hepatoid Adenocarcinoma of Gallbladder With MB21D2/GALNT12/ARID2 Mutations: A Case Report.
Li Z; Jiang Q; Chen X; Xiao Y; Xiao J
Front Endocrinol (Lausanne); 2021; 12():791153. PubMed ID: 35046897
[TBL] [Abstract][Full Text] [Related]
13. The mucin-type glycosylating enzyme polypeptide N-acetylgalactosaminyltransferase 14 promotes the migration of ovarian cancer by modifying mucin 13.
Wang R; Yu C; Zhao D; Wu M; Yang Z
Oncol Rep; 2013 Aug; 30(2):667-76. PubMed ID: 23708057
[TBL] [Abstract][Full Text] [Related]
14. Role of GALNT12 in the genetic predisposition to attenuated adenomatous polyposis syndrome.
Lorca V; Rueda D; Martín-Morales L; Poves C; Fernández-Aceñero MJ; Ruiz-Ponte C; Llovet P; Marrupe D; García-Barberán V; García-Paredes B; Pérez-Segura P; de la Hoya M; Díaz-Rubio E; Caldés T; Garre P
PLoS One; 2017; 12(11):e0187312. PubMed ID: 29095867
[TBL] [Abstract][Full Text] [Related]
15. Critical Role of Estrogen Receptor Alpha O-Glycosylation by N-Acetylgalactosaminyltransferase 6 (GALNT6) in Its Nuclear Localization in Breast Cancer Cells.
Deng B; Tarhan YE; Ueda K; Ren L; Katagiri T; Park JH; Nakamura Y
Neoplasia; 2018 Oct; 20(10):1038-1044. PubMed ID: 30208353
[TBL] [Abstract][Full Text] [Related]
16. Inactivating mutations of proapoptotic Bad gene in human colon cancers.
Lee JW; Soung YH; Kim SY; Nam SW; Kim CJ; Cho YG; Lee JH; Kim HS; Park WS; Kim SH; Lee JY; Yoo NJ; Lee SH
Carcinogenesis; 2004 Aug; 25(8):1371-6. PubMed ID: 15033904
[TBL] [Abstract][Full Text] [Related]
17. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability.
Cunningham JM; Christensen ER; Tester DJ; Kim CY; Roche PC; Burgart LJ; Thibodeau SN
Cancer Res; 1998 Aug; 58(15):3455-60. PubMed ID: 9699680
[TBL] [Abstract][Full Text] [Related]
18. Changes in the profile of simple mucin-type O-glycans and polypeptide GalNAc-transferases in human testis and testicular neoplasms are associated with germ cell maturation and tumour differentiation.
Rajpert-De Meyts E; Poll SN; Goukasian I; Jeanneau C; Herlihy AS; Bennett EP; Skakkebaek NE; Clausen H; Giwercman A; Mandel U
Virchows Arch; 2007 Oct; 451(4):805-14. PubMed ID: 17694322
[TBL] [Abstract][Full Text] [Related]
19. BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair.
Wang L; Cunningham JM; Winters JL; Guenther JC; French AJ; Boardman LA; Burgart LJ; McDonnell SK; Schaid DJ; Thibodeau SN
Cancer Res; 2003 Sep; 63(17):5209-12. PubMed ID: 14500346
[TBL] [Abstract][Full Text] [Related]
20. Early onset MSI-H colon cancer with MLH1 promoter methylation, is there a genetic predisposition?
van Roon EH; van Puijenbroek M; Middeldorp A; van Eijk R; de Meijer EJ; Erasmus D; Wouters KA; van Engeland M; Oosting J; Hes FJ; Tops CM; van Wezel T; Boer JM; Morreau H
BMC Cancer; 2010 May; 10():180. PubMed ID: 20444249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
